Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Radiotherapy as a tool fo… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Radiotherapy as a tool for the treatment of Cushing's disease

Artikel i vetenskaplig tidskrift
Författare Frederic Castinetti
Thierry Brue
Oskar Ragnarsson
Publicerad i European Journal of Endocrinology
Volym 180
Nummer/häfte 5
Sidor D9-D18
ISSN 0804-4643
Publiceringsår 2019
Publicerad vid Institutionen för medicin, avdelningen för invärtesmedicin och klinisk nutrition
Sidor D9-D18
Språk en
Länkar dx.doi.org/10.1530/eje-19-0092
Ämnesord term-follow-up, gamma-knife surgery, fractionated stereotactic, radiotherapy, postoperative radiation-therapy, 2nd brain-tumor, pituitary-adenomas, glucocorticoid replacement, transsphenoidal surgery, adult patients, conservative surgery, Endocrinology & Metabolism
Ämneskategorier Endokrinologi och diabetes

Sammanfattning

Treatment of Cushing's disease (CD) is one of the most challenging tasks in endocrinology. The first-line treatment, transsphenoidal pituitary surgery, is associated with a high failure rate and a high prevalence of recurrence. Re-operation is associated with an even higher rate of a failure and recurrence. There are three main second-line treatments for CD - pituitary radiation therapy (RT), bilateral adrenalectomy and chronic cortisol-lowering medical treatment. All these treatments have their limitations. While bilateral adrenalectomy provides permanent cure of the hypercortisolism in all patients, the unavoidable chronic adrenal insufficiency and the risk of development of Nelson syndrome are of concern. Chronic cortisol-lowering medical treatment is not efficient in all patients and side effects are often a limiting factor. RT is efficient for approximately two-thirds of all patients with CD. However, the high prevalence of pituitary insufficiency is of concern as well as potential optic nerve damage, development of cerebrovascular disease and secondary brain tumours. Thus, when it comes to decide appropriate treatment for patients with CD, who have either failed to achieve remission with pituitary surgery, or patients with recurrence, the pros and cons of all second-line treatment options must be considered.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?